Citations

Clear

3138 citation(s) found for "Smith, AM".

A Brief Report on WAIS-R Normative Data Collection in Mayo's Older African Americans Normative Studies
Lucas, John A. , Ivnik, Robert J., Smith, Glenn E. , Ferman, Tanis J. , Willis, Floyd B. , Petersen, Ronald C. , Graff‐Radford, Neill R., Ferman, Tanis J

Mayo Clinic

The Clinical Neuropsychologist | January 3, 2006 | Volume: 19 | Issue: 2 | Pages: 184-188

10.1080/13854040590945283 | PMID 16019703 Get It

Mayo's Older African Americans Normative Studies: Normative Data for Commonly Used Clinical Neuropsychological Measures
Lucas, John A. , Ivnik, Robert J., Willis, Floyd B. , Ferman, Tanis J. , Smith, Glenn E. , Parfitt, Francine, Petersen, Ronald C. , Graff‐Radford, Neill R. , Ferman, Tanis J

Mayo Clinic

The Clinical Neuropsychologist | January 3, 2006 | Volume: 19 | Issue: 2 | Pages: 162-183

10.1080/13854040590945265 | PMID 16019702 Get It

Human TopBP1 Ensures Genome Integrity during Normal S Phase
Kim, Ja‐Eun , McAvoy, Sarah , Smith, David I., Smith, David I., Chen, Junjie

Mayo Clinic

Molecular and Cellular Biology | November 28, 2005 | Volume: 25 | Issue: 24 | Pages: 10907-10915

10.1128/mcb.25.24.10907-10915.2005 | PMID 16314514 Get It

Use of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Hospital Setting
Boyle, Mary E., Cisar, Nancy, Miller-Cage, Victoria, Bourgeois, Peggy B., Roust, Lori R., Smith, Steven A., Zimmerman, Richard S. , Cook, Curtiss B.

Mayo Clinic

The Diabetes Educator | November 15, 2005 | Volume: 31 | Issue: 6 | Pages: 849-857

10.1177/0145721705281563 | PMID 16288092 Get It

Purpose Individuals whose diabetes is being treated in the outpatient setting via an insulin pump often wish to maintain this therapy during hospitalization. The authors propose guidelines for management of patients on insulin pumps who require a hospital admission. Methods A collaborative interinstitutional task force reviewed current available information regarding the use of insulin pumps in the hospital. Results There was little information in the medical literature on how to manage individuals on established insulin pump therapy during a hospital stay. The task force believed that a policy that promotes patient independence through continuation of insulin pump therapy while ensuring patient safety was possible. A set of contraindications for continued use of pump therapy in the hospital are proposed. A sample patient consent form and order set are presented. Finally, measures that can be used to assess effectiveness of an inpatient insulin pump policy are outlined. Conclusions Patients on established insulin pump therapy do not necessarily have to discontinue treatment while hospitalized. However, clear policies and procedures should be established at the institutional level to guide continued use of the technology in the acute care setting.
Role of Endothelial NO Synthase Phosphorylation in Cerebrovascular Protective Effect of Recombinant Erythropoietin During Subarachnoid Hemorrhage– Induced Cerebral Vasospasm
Santhanam, Anantha Vijay R., Akiyama, Masahiko, Rosales, A. Gabriela , Bailey, Kent R. , Katušić, Zvonimir S. , Smith, Leslie

Mayo Clinic

Stroke | November 4, 2005 | Volume: 36 | Issue: 12 | Pages: 2731-2737

10.1161/01.str.0000190021.85035.5b | PMID 16269632 Get It

Background and Purpose— In the present study, the effect of subarachnoid hemorrhage (SAH) on the phosphorylation of endothelial NO synthase (eNOS) and the ability of recombinant erythropoietin (Epo) to augment this vasodilator mechanism in the spastic arteries were studied. Methods— Recombinant adenoviral vectors (10 9 plaque-forming units per animal) encoding genes for human Epo (AdEpo), and β-galactosidase were injected immediately after injection of autologous arterial blood into the cisterna magna (day 0) of rabbits. Cerebral angiography was performed on day 0 and day 2, and basilar arteries were harvested for Western blots, measurement of cGMP levels, and analysis of vasomotor functions. Results— Injection of autologous arterial blood into cisterna magna resulted in significant vasospasm of the basilar arteries. Despite the narrowing of arterial diameter and reduced expression of eNOS, expressions of phosphorylated protein kinase B (Akt) and phosphorylated eNOS were significantly increased in spastic arteries. Gene transfer of AdEpo reversed the vasospasm. AdEpo-transduced basilar arteries demonstrated significant augmentation of the endothelium-dependent relaxations to acetylcholine, whereas the relaxations to an NO donor, 2-( N , N -diethylamino)diazenolate-2-oxide sodium salt, were not affected. Transduction with AdEpo further increased the expression of phosphorylated Akt and eNOS and elevated basal levels of cGMP in the spastic arteries. Conclusions— Phosphorylation of eNOS appears to be an adaptive mechanism activated during development of vasospasm. The vascular protective effect of Epo against cerebral vasospasm induced by SAH may be mediated in part by phosphorylation of Akt/eNOS.
Prospective Comparison of Cell Cultures and Nucleic Acid Amplification Tests for Laboratory Diagnosis of Chlamydia trachomatis Infections
Jespersen, Deborah J., Flatten, Karen S., Jones, Mary F. , Smith, Thomas F.

Mayo Clinic

Journal of Clinical Microbiology | October 5, 2005 | Volume: 43 | Issue: 10 | Pages: 5324-5326

10.1128/jcm.43.10.5324-5326.2005 | PMID 16208009 Get It

ABSTRACT Specimens submitted in M5 medium for cell culture detection of Chlamydia trachomatis were tested by nucleic acid amplification testing (NAAT) and in cell cultures. Of 35 (genital) and 26 (nongenital) specimens positive for C. trachomatis , 21 and 14 specimens, respectively, were detected exclusively by NAAT. NAAT is significantly ( P < 0.0001) more sensitive than cell culture and should be considered the new “gold standard” for the laboratory diagnosis of C. trachomatis infections.
Human Telomerase Reverse Transcriptase Gene Expression and the Surgical Management of Suspicious Thyroid Tumors
Umbricht, Christopher B. , Conrad, George T., Clark, Douglas P. , Westra, William H. , Smith, Dañelle C., Zahurak, Marianna , Saji, Motoyasu , Smallridge, Robert C., Zeiger, Martha A. , Goodman, Steven N.

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 10 | Issue: 17 | Pages: 5762-5768

10.1158/1078-0432.ccr-03-0389 | PMID 15355904 Get It

Abstract Purpose: Patients with a preoperative cytologic diagnosis of a suspicious thyroid nodule present a therapeutic dilemma because surgery differs for benign and malignant lesions. To address this issue, several molecular markers, including human telomerase reverse transcriptase (TERT), have been tested as markers of thyroid cancer. Because most studies select cases falling into well-defined categories to test new markers, they may overestimate their discriminatory power when applied to samples that are difficult to classify. Fine-needle aspirates (FNAs) of the thyroid with indeterminate cytology are an example of such cases. Experimental Design: We examined whether assessing TERT mRNA by reverse transcription-PCR could have improved the surgical management in a cohort of 100 patients undergoing thyroidectomy for indeterminate FNA results. Results: Ninety percent of 48 cancers were TERT positive, as were 35% of 52 benign lesions. When 10 cases with concomitant lymphocytic thyroiditis were excluded, the overall sensitivity of TERT was 91% (95% confidence interval, 80–98%) and specificity was 79% (64–90%). No clinical or tumor variable contributed to the predictive ability of TERT except for tumor size, which added only marginally. Basing the surgical approach on the TERT assay alone would have reduced lobectomies performed for malignant disease from 11 to 4 cases and reduced total thyroidectomies for benign lesions from to 15 to 9, an overall 50% reduction in suboptimal treatment. Conclusions: The overall performance of preoperative differential diagnosis for thyroid tumors with indeterminate FNA results can be substantially improved by the inclusion of molecular markers such as TERT.
Selection of Potential Markers for Epithelial Ovarian Cancer with Gene Expression Arrays and Recursive Descent Partition Analysis
Lu, Karen H. , Patterson, Andrea P., Marquez, Rebecca T., Atkinson, E. Neely, Baggerly, Keith, Ramoth, Lance R., Rosen, Daniel , Hellström, Ingegerd, Smith, David, Hartmann, Lynn C. , Fishman, David A. , Schmandt, Rosemarie , Whitaker, Regina S. , Bast, Robert C. , Wang, Lin , Liu, Jinsong , Smith, David, Berchuck, Andrew , Gershenson, David M. , Mills, Gordon B. , Bast, Robert C

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 10 | Issue: 10 | Pages: 3291-3300

10.1158/1078-0432.ccr-03-0409 | PMID 15161682 Get It

Abstract Purpose: Advanced-stage epithelial ovarian cancer has a poor prognosis with long-term survival in less than 30% of patients. When the disease is detected in stage I, more than 90% of patients can be cured by conventional therapy. Screening for early-stage disease with individual serum tumor markers, such as CA125, is limited by the fact that no single marker is up-regulated and shed in adequate amounts by all ovarian cancers. Consequently, use of multiple markers in combination might detect a larger fraction of early-stage ovarian cancers. Experimental Design: To identify potential candidates for novel markers, we have used Affymetrix human genome arrays (U95 series) to analyze differences in gene expression of 41,441 known genes and expressed sequence tags between five pools of normal ovarian surface epithelial cells (OSE) and 42 epithelial ovarian cancers of different stages, grades, and histotypes. Recursive descent partition analysis (RDPA) was performed with 102 probe sets representing 86 genes that were up-regulated at least 3-fold in epithelial ovarian cancers when compared with normal OSE. In addition, a panel of 11 genes known to encode potential tumor markers [mucin 1, transmembrane (MUC1), mucin 16 (CA125), mesothelin, WAP four-disulfide core domain 2 (HE4), kallikrein 6, kallikrein 10, matrix metalloproteinase 2, prostasin, osteopontin, tetranectin, and inhibin] were similarly analyzed. Results: The 3-fold up-regulated genes were examined and four genes [Notch homologue 3 (NOTCH3), E2F transcription factor 3 (E2F3), GTPase activating protein (RACGAP1), and hematological and neurological expressed 1 (HN1)] distinguished all tumor samples from normal OSE. The 3-fold up-regulated genes were analyzed using RDPA, and the combination of elevated claudin 3 (CLDN3) and elevated vascular endothelial growth factor (VEGF) distinguished the cancers from normal OSE. The 11 known markers were analyzed using RDPA, and a combination of HE4, CA125, and MUC1 expression could distinguish tumor from normal specimens. Expression at the mRNA level in the candidate markers was examined via semiquantitative reverse transcription-PCR and was found to correlate well with the array data. Immunohistochemistry was performed to identify expression of the genes at the protein level in 158 ovarian cancers of different histotypes. A combination of CLDN3, CA125, and MUC1 stained 157 (99.4%) of 158 cancers, and all of the tumors were detected with a combination of CLDN3, CA125, MUC1, and VEGF. Conclusions: Our data are consistent with the possibility that a limited number of markers in combination might identify &gt;99% of epithelial ovarian cancers despite the heterogeneity of the disease.
Patterns of Gene Expression in Different Histotypes of Epithelial Ovarian Cancer Correlate with Those in Normal Fallopian Tube, Endometrium, and Colon
Marquez, Rebecca T., Baggerly, Keith, Patterson, Andrea P., Broaddus, Russell, Atkinson, E. Neely, Smith, David I., Hartmann, Lynn C. , Fishman, David A. , Whitaker, Regina S. , Bast, Robert C. , Lu, Karen H. , Liu, Jinsong , Frumovitz, Michael , Smith, David I., Berchuck, Andrew , Gershenson, David M. , Mills, Gordon B. , Bast, Robert C

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 11 | Issue: 17 | Pages: 6116-6126

10.1158/1078-0432.ccr-04-2509 | PMID 16144910 Get It

Abstract Purpose: Epithelial ovarian cancers are thought to arise from flattened epithelial cells that cover the ovarian surface or that line inclusion cysts. During malignant transformation, different histotypes arise that resemble epithelial cells from normal fallopian tube, endometrium, and intestine. This study compares gene expression in serous, endometrioid, clear cell, and mucinous ovarian cancers with that in the normal tissues that they resemble. Experimental Design: Expression of 63,000 probe sets was measured in 50 ovarian cancers, in 5 pools of normal ovarian epithelial brushings, and in mucosal scrapings from 4 normal fallopian tube, 5 endometrium, and 4 colon specimens. Using rank-sum analysis, genes whose expressions best differentiated the ovarian cancer histotypes and normal ovarian epithelium were used to determine whether a correlation based on gene expression existed between ovarian cancer histotypes and the normal tissues they resemble. Results: When compared with normal ovarian epithelial brushings, alterations in serous tumors correlated with those in normal fallopian tube (P = 0.0042) but not in other normal tissues. Similarly, mucinous cancers correlated with those in normal colonic mucosa (P = 0.0003), and both endometrioid and clear cell histotypes correlated with changes in normal endometrium (P = 0.0172 and 0.0002, respectively). Mucinous cancers displayed the greatest number of alterations in gene expression when compared with normal ovarian epithelial cells. Conclusion: Studies at a molecular level show distinct expression profiles of different histologies of ovarian cancer and support the long-held belief that histotypes of ovarian cancers come to resemble normal fallopian tube, endometrial, and colonic epithelium. Several potential molecular markers for mucinous ovarian cancers have been identified.
Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
Hartmann, Lynn C. , Lu, Karen H. , Linette, Gerald P. , Cliby, William A. , Kalli, Kimberly R., Bast, Robert C. , Stec, James , Iartchouk, Natalia, Smith, David I., Hoersch, Sebastian, Shridhar, Viji , Lillie, James W., Clark, Edwin, Damokosh, Andrew I., Gershenson, David M. , Smith, David I., Ross, Jeffrey S. , Kaufmann, Scott H. , Bast, Robert C

Mayo Clinic

Clinical Cancer Research | September 21, 2005 | Volume: 11 | Issue: 6 | Pages: 2149-2155

10.1158/1078-0432.ccr-04-1673 | PMID 15788660 Get It

Abstract Purpose: Women with advanced epithelial ovarian cancer are routinely treated with platinum-paclitaxel chemotherapy following cytoreductive surgery, yet only ∼20% achieve long-term disease-free survival. We hypothesized that differences in gene expression before treatment could distinguish patients with short versus long time to recurrence after administration of platinum-paclitaxel combination chemotherapy. Experimental Design: To test this hypothesis, gene expression profiling of 79 primary surgically resected tumors from women with advanced-stage, high-grade epithelial ovarian cancer was done using cDNA microarrays containing 30,721 genes. Supervised learning algorithms were applied in an effort to develop a binary classifier that could discriminate women at risk for early (≤21 months) versus late (&gt;21 months) relapse after initial chemotherapy. Results: A 14-gene predictive model was developed using a set of training samples (n = 51) and subsequently tested using an independent set of test samples (n = 28). This model correctly predicted the outcome of 24 of the 28 test samples (86% accuracy) with 95% positive predictive value for early relapse. Conclusions: Predictive markers for early recurrence can be identified for platinum-paclitaxel combination chemotherapy in primary ovarian carcinoma. The proposed 14-gene model requires further validation.